https://neuroeconomix.com/es/blog/ 2025-01-27T08:15:50+00:00 https://neuroeconomix.com/es/data-mining-y-knowledge-discovery-databases-dos-herramientas-claves-en-el-analisis-de-datos/ 2026-08-20T17:21:09+00:00 https://neuroeconomix.com/es/introduccion-data-mining/ 2026-08-20T16:38:12+00:00 https://neuroeconomix.com/es/la-ia-ya-llego-a-medical-affairs/ 2026-08-13T00:47:50+00:00 https://neuroeconomix.com/wp-content/uploads/2026/08/185.png https://neuroeconomix.com/wp-content/uploads/2026/08/186.png https://neuroeconomix.com/wp-content/uploads/2026/08/187.png https://neuroeconomix.com/wp-content/uploads/2026/08/188.png https://neuroeconomix.com/wp-content/uploads/2026/08/189.png https://neuroeconomix.com/wp-content/uploads/2026/08/190.png https://neuroeconomix.com/wp-content/uploads/2026/08/191.png https://neuroeconomix.com/wp-content/uploads/2026/08/192.png https://neuroeconomix.com/wp-content/uploads/2026/08/193.png https://neuroeconomix.com/es/el-costo-invisible-del-cuidador-en-las-decisiones-de-salud/ 2026-08-03T14:24:32+00:00 https://neuroeconomix.com/es/healthtech-el-nuevo-motor-de-la-inversion-extranjera-en-salud-en-colombia/ 2026-07-29T19:37:48+00:00 https://neuroeconomix.com/es/acuerdos-de-acceso-por-resultados-meas/ 2026-07-15T14:30:08+00:00 https://neuroeconomix.com/wp-content/uploads/2026/07/178.png https://neuroeconomix.com/wp-content/uploads/2026/07/179.png https://neuroeconomix.com/wp-content/uploads/2026/07/180.png https://neuroeconomix.com/wp-content/uploads/2026/07/181.png https://neuroeconomix.com/wp-content/uploads/2026/07/182.png https://neuroeconomix.com/wp-content/uploads/2026/07/183.png https://neuroeconomix.com/wp-content/uploads/2026/07/184.png https://neuroeconomix.com/es/sesgos-en-los-datos-de-vida-real/ 2026-07-07T13:00:00+00:00 https://neuroeconomix.com/es/por-que-hay-ips-que-reportan-utilidades-en-medio-de-la-crisis-del-sector-salud/ 2026-07-02T13:00:00+00:00 https://neuroeconomix.com/es/farmacoeconomia-para-equipos-de-medical-affairs/ 2026-06-26T13:00:00+00:00 https://neuroeconomix.com/es/el-nuevo-rol-del-heor-manager-en-la-era-de-la-ia-generativa/ 2026-06-18T16:51:16+00:00 https://neuroeconomix.com/es/puedes-presentar-evidencia-generada-con-ia-ante-nice-conitec-e-iets/ 2026-06-16T20:02:09+00:00 https://neuroeconomix.com/wp-content/uploads/2026/06/1.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/2.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/3.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/4.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/5.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/6.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/7.jpg https://neuroeconomix.com/wp-content/uploads/2026/06/8.jpg https://neuroeconomix.com/es/evidencia-local-en-salud/ 2026-06-10T14:57:01+00:00 https://neuroeconomix.com/es/como-se-construye-una-value-story-para-payers-latinoamericanos/ 2026-06-11T19:00:00+00:00 https://neuroeconomix.com/es/acuerdos-de-acceso-por-resultados-meas-en-america-latina/ 2026-06-04T19:59:55+00:00 https://neuroeconomix.com/es/por-que-fracasan-las-intervenciones-de-las-eps/ 2026-06-03T17:23:30+00:00 https://neuroeconomix.com/es/icer-qalys-y-budget-impact-models/ 2026-05-28T21:00:43+00:00 https://neuroeconomix.com/es/la-actualizacion-del-pbs-en-colombia-cambio-las-reglas-del-juego-para-la-industria-farmaceutica/ 2026-05-19T17:10:52+00:00 https://neuroeconomix.com/wp-content/uploads/2026/05/162.png https://neuroeconomix.com/wp-content/uploads/2026/05/163.png https://neuroeconomix.com/wp-content/uploads/2026/05/164.png https://neuroeconomix.com/wp-content/uploads/2026/05/165.png https://neuroeconomix.com/wp-content/uploads/2026/05/166.png https://neuroeconomix.com/wp-content/uploads/2026/05/167.png https://neuroeconomix.com/wp-content/uploads/2026/05/168.png https://neuroeconomix.com/wp-content/uploads/2026/05/169.png https://neuroeconomix.com/es/como-construir-un-equipo-de-medical-affairs-listo-para-la-era-de-la-ia-generativa/ 2026-05-12T21:00:12+00:00 https://neuroeconomix.com/es/tendencias-en-la-venta-de-medicamentos-de-alto-costo/ 2026-05-12T16:18:14+00:00 https://neuroeconomix.com/es/mujeres-en-salud-entre-el-liderazgo-pendiente-y-las-brechas-persistentes/ 2026-05-07T13:05:04+00:00 https://neuroeconomix.com/es/puedes-presentar-evidencia-generada-con-ia-ante-nice-conitec-e-iets-la-respuesta-en-2026/ 2026-04-29T19:46:32+00:00 https://neuroeconomix.com/es/latam-vale-100b-en-medicamentos-para-2030-la-ventana-para-posicionarse-en-market-access-se-esta-cerrando/ 2026-04-22T15:13:11+00:00 https://neuroeconomix.com/es/del-ensayo-clinico-a-la-evidencia-del-mundo-real-2/ 2026-04-20T18:02:14+00:00 https://neuroeconomix.com/wp-content/uploads/2026/04/154.png https://neuroeconomix.com/wp-content/uploads/2026/04/155.png https://neuroeconomix.com/wp-content/uploads/2026/04/156.png https://neuroeconomix.com/wp-content/uploads/2026/04/157.png https://neuroeconomix.com/wp-content/uploads/2026/04/158.png https://neuroeconomix.com/wp-content/uploads/2026/04/159.png https://neuroeconomix.com/wp-content/uploads/2026/04/160.png https://neuroeconomix.com/wp-content/uploads/2026/04/161.png https://neuroeconomix.com/es/la-ia-en-pharma-esta-sobrevalorada-excepto-en-market-access-por-que/ 2026-04-17T16:23:16+00:00 https://neuroeconomix.com/es/cuanto-le-esta-costando-a-tu-equipo-construir-un-dossier-de-valor-sin-ia/ 2026-04-17T16:19:43+00:00 https://neuroeconomix.com/es/como-la-inteligencia-artificial-puede-asistir-la-construccion-de-value-dossiers-en-pharma/ 2026-04-09T11:56:11+00:00 https://neuroeconomix.com/es/8-formas-realistas-de-usar-inteligencia-artificial-en-tu-hospital-en-colombia/ 2026-04-07T15:32:47+00:00 https://neuroeconomix.com/es/la-orden-del-tribunal-administrativo-de-antioquia-sobre-el-traslado-masivo-de-afiliados-entre-eps/ 2026-03-25T23:16:07+00:00 https://neuroeconomix.com/es/del-ensayo-clinico-a-la-evidencia-del-mundo-real/ 2026-03-19T14:02:19+00:00 https://neuroeconomix.com/wp-content/uploads/2026/03/145-1.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/146.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/147.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/148.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/149.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/150.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/151.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/152.jpg https://neuroeconomix.com/wp-content/uploads/2026/03/153.jpg https://neuroeconomix.com/es/financiamiento-y-gobernanza-del-aseguramiento-en-salud-analizando-el-caso-de-las-eps/ 2026-03-12T18:32:20+00:00 https://neuroeconomix.com/es/los-pacientes-en-colombia-esperan-mas-de-cinco-anos-para-tener-acceso-a-medicamentos-innovadores-indicador-w-a-i-t-2025/ 2026-02-20T16:27:01+00:00 https://neuroeconomix.com/wp-content/uploads/2026/02/134-2.png https://neuroeconomix.com/wp-content/uploads/2026/02/135.png https://neuroeconomix.com/wp-content/uploads/2026/02/136.png https://neuroeconomix.com/wp-content/uploads/2026/02/137.png https://neuroeconomix.com/wp-content/uploads/2026/02/138.png https://neuroeconomix.com/wp-content/uploads/2026/02/139.png https://neuroeconomix.com/wp-content/uploads/2026/02/140.png https://neuroeconomix.com/wp-content/uploads/2026/02/141.png https://neuroeconomix.com/wp-content/uploads/2026/02/142.png https://neuroeconomix.com/wp-content/uploads/2026/02/143.png https://neuroeconomix.com/wp-content/uploads/2026/02/144.png https://neuroeconomix.com/es/actualizacion-del-pbs-en-colombia-para-2026/ 2026-02-05T13:48:54+00:00 https://neuroeconomix.com/es/los-5-temas-de-salud-que-mas-impactaron-en-2025-lo-mas-leido-en-neuroeconomix/ 2025-12-11T12:52:30+00:00 https://neuroeconomix.com/es/la-era-del-valor-en-colombia-esta-tu-tecnologia-lista/ 2025-11-27T15:45:19+00:00 https://neuroeconomix.com/wp-content/uploads/2025/11/127-e1764258047350.png https://neuroeconomix.com/wp-content/uploads/2025/11/128.png https://neuroeconomix.com/wp-content/uploads/2025/11/129.png https://neuroeconomix.com/wp-content/uploads/2025/11/130.png https://neuroeconomix.com/wp-content/uploads/2025/11/131.png https://neuroeconomix.com/wp-content/uploads/2025/11/132.png https://neuroeconomix.com/wp-content/uploads/2025/11/133.png https://neuroeconomix.com/es/la-reforma-a-la-salud-en-colombia-entre-la-promesa-de-equidad-y-los-riesgos-de-transicion/ 2025-11-13T13:03:43+00:00 https://neuroeconomix.com/es/impacto-de-las-medidas-arancelarias-de-ee-uu-al-sector-farmaceutico-en-colombia/ 2025-10-31T14:47:51+00:00 https://neuroeconomix.com/es/invimagil-digitalizacion-regulatoria-para-una-gestion-sanitaria-mas-eficiente-en-colombia/ 2025-10-31T14:46:01+00:00 https://neuroeconomix.com/es/inteligencia-artificial-en-salud-entre-la-innovacion-y-los-desafios/ 2025-10-31T14:45:34+00:00 https://neuroeconomix.com/es/suministro-de-medicamentos-en-colombia-desabastecimiento-escasez-o-barreras-de-acceso/ 2025-10-31T14:45:04+00:00 https://neuroeconomix.com/es/la-actualizacion-del-plan-de-beneficios-en-salud-en-colombia-buscando-el-balance-entre-acceso-y-sostenibilidad/ 2025-10-31T14:29:44+00:00 https://neuroeconomix.com/wp-content/uploads/2025/07/img-blog-PBS-acceso2.png https://neuroeconomix.com/es/las-ordenes-de-la-corte-constitucional-sobre-el-sobrecosto-de-medicamentos/ 2025-10-23T16:24:30+00:00 https://neuroeconomix.com/es/del-bolsillo-a-la-evidencia-apps-y-wearables-como-fuentes-de-informacion-cientifica/ 2025-10-02T14:04:06+00:00 https://neuroeconomix.com/es/las-cifras-del-giro-directo-en-2025/ 2025-09-25T14:41:47+00:00 https://neuroeconomix.com/es/el-modelo-de-atencion-en-salud-preventivo-predictivo-y-resolutivo/ 2025-08-14T13:04:21+00:00 https://neuroeconomix.com/es/elevator-pitch-la-habilidad-que-puede-abrir-o-cerrar-puertas-en-segundos/ 2025-08-06T12:17:49+00:00 https://neuroeconomix.com/wp-content/uploads/2025/08/121-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/08/121.jpg https://neuroeconomix.com/wp-content/uploads/2025/08/122.jpg https://neuroeconomix.com/wp-content/uploads/2025/08/123.jpg https://neuroeconomix.com/wp-content/uploads/2025/08/124.jpg https://neuroeconomix.com/wp-content/uploads/2025/08/125.jpg https://neuroeconomix.com/wp-content/uploads/2025/08/126.jpg https://neuroeconomix.com/es/el-proceso-de-recuperacion-empresarial-y-su-aplicacion-para-eps-e-ips/ 2025-07-17T13:47:53+00:00 https://neuroeconomix.com/es/las-cuentas-nacionales-del-personal-de-salud/ 2025-06-26T13:26:51+00:00 https://neuroeconomix.com/es/la-estimacion-de-costos-en-salud-en-colombia-una-tarea-pendiente-para-fortalecer-las-evaluaciones-economicas/ 2025-06-19T13:30:44+00:00 https://neuroeconomix.com/es/estrategia-para-convertir-tus-datos-en-una-historia-de-valor-arrolladora/ 2025-06-12T12:56:34+00:00 https://neuroeconomix.com/wp-content/uploads/2025/05/107-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/05/108.jpg https://neuroeconomix.com/wp-content/uploads/2025/05/109.jpg https://neuroeconomix.com/wp-content/uploads/2025/05/110.jpg https://neuroeconomix.com/wp-content/uploads/2025/05/111.jpg https://neuroeconomix.com/wp-content/uploads/2025/05/112.jpg https://neuroeconomix.com/wp-content/uploads/2025/05/113.jpg https://neuroeconomix.com/es/4-errores-al-contar-la-historia-de-valor-de-tu-tecnologia/ 2025-06-12T12:53:24+00:00 https://neuroeconomix.com/wp-content/uploads/2025/06/114.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/114-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/115.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/116.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/117.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/118.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/119.jpg https://neuroeconomix.com/wp-content/uploads/2025/06/120.jpg https://neuroeconomix.com/es/colombia-es-el-unico-pais-con-su-sistema-de-salud-en-crisis/ 2025-05-28T12:59:06+00:00 https://neuroeconomix.com/es/los-fondos-de-la-ops/ 2025-05-15T13:43:15+00:00 https://neuroeconomix.com/wp-content/uploads/2025/05/image.png https://neuroeconomix.com/es/la-mesa-de-trabajo-para-la-revision-de-la-unidad-de-pago-por-capitacion-upc/ 2025-03-27T12:57:32+00:00 https://neuroeconomix.com/es/sistema-de-salud-en-colombia-que-podemos-esperar-para-el-2024/ 2025-03-26T18:49:48+00:00 https://neuroeconomix.com/es/tecnologias-digitales-en-salud-que-debemos-saber-para-ofrecer-calidad-y-uso-seguro-para-los-pacientes/ 2025-03-26T18:48:35+00:00 https://neuroeconomix.com/wp-content/uploads/2023/09/5.png https://neuroeconomix.com/wp-content/uploads/2023/09/1.png https://neuroeconomix.com/wp-content/uploads/2023/09/2.png https://neuroeconomix.com/wp-content/uploads/2023/09/3.png https://neuroeconomix.com/wp-content/uploads/2023/09/4.png https://neuroeconomix.com/es/evaluacion-de-tecnologias-digitales-en-salud-cuales-atributos-se-deben-valorar-cual-es-la-regulacion-aplicable/ 2025-03-26T18:47:32+00:00 https://neuroeconomix.com/wp-content/uploads/2023/10/imagen1-blog2-Kariluz.png https://neuroeconomix.com/wp-content/uploads/2023/10/imagen2-blog2-Kariluz.png https://neuroeconomix.com/wp-content/uploads/2023/10/imagen3-blog2-Kariluz.png https://neuroeconomix.com/es/cuestionando-los-fundamentos-del-analisis-de-costo-efectividad-es-un-qaly-solo-un-qaly/ 2025-03-13T12:43:34+00:00 https://neuroeconomix.com/es/analisis-de-decision-multicriterio-mcda-en-el-cuidado-de-la-salud/ 2025-03-05T20:13:32+00:00 https://neuroeconomix.com/wp-content/uploads/2024/09/68-e1741205590549.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/69.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/70.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/71.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/72.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/73.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/74.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/75.jpg https://neuroeconomix.com/wp-content/uploads/2024/09/76.jpg https://neuroeconomix.com/es/la-inteligencia-artificial-ia-para-el-desarrollo-de-las-revisiones-sistematicas-de-la-literatura-rsl/ 2025-03-05T20:11:05+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/77-ias.png https://neuroeconomix.com/wp-content/uploads/2025/02/78.png https://neuroeconomix.com/wp-content/uploads/2025/02/79.png https://neuroeconomix.com/wp-content/uploads/2025/02/80.png https://neuroeconomix.com/wp-content/uploads/2025/02/81.png https://neuroeconomix.com/wp-content/uploads/2025/02/82.png https://neuroeconomix.com/wp-content/uploads/2025/02/83.png https://neuroeconomix.com/wp-content/uploads/2025/02/84.png https://neuroeconomix.com/wp-content/uploads/2025/02/85.png https://neuroeconomix.com/es/negociacion-en-el-sector-farma/ 2025-03-05T16:37:29+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/1-negoc-e1741192525377.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/7-negoc.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/6-negoc.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/5-negoc.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/4-negoc.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/3-negoc.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/2-negoc.jpg https://neuroeconomix.com/es/el-poder-del-storytelling-en-el-marketing-farmaceutico/ 2025-03-05T16:32:38+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/1-e1741192350728.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/4.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/3.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/2.jpg https://neuroeconomix.com/es/sistema-de-salud-en-colombia-10-avances-clave-en-los-ultimos-anos/ 2025-03-05T16:30:23+00:00 https://neuroeconomix.com/wp-content/uploads/2024/11/86-e1741192212304.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/87.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/88.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/89.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/90.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/91.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/92.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/93.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/94.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/95.jpg https://neuroeconomix.com/wp-content/uploads/2024/11/96.jpg https://neuroeconomix.com/es/medicamentos-para-enfermedades-huerfanas-cuantos-se-encuentran-disponibles-en-colombia/ 2025-03-05T16:23:56+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/1-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/2-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/3-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/4-1.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/5.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/6.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/7.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/8.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/9.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/10.jpg https://neuroeconomix.com/es/las-recientes-ordenes-de-la-corte-constitucional-sobre-la-upc/ 2025-02-20T13:05:12+00:00 https://neuroeconomix.com/es/actualizacion-del-pbs-en-colombia-para-el-2025-resolucion-2718-de-2024-que-cambio/ 2025-02-07T14:38:49+00:00 https://neuroeconomix.com/es/aspectos-relevantes-sobre-la-reforma-a-la-salud-presentada-por-la-ministra-de-salud/ 2025-02-07T12:15:49+00:00 https://neuroeconomix.com/es/por-que-no-coinciden-las-cifras-sobre-las-deudas-entre-eps-e-ips/ 2025-02-07T12:15:04+00:00 https://neuroeconomix.com/es/sistema-de-salud-en-colombia-7-avances-y-medidas-hacia-la-cobertura-universal-en-salud/ 2025-02-07T12:14:15+00:00 https://neuroeconomix.com/wp-content/uploads/2023/02/Imagen1.png https://neuroeconomix.com/wp-content/uploads/2023/02/Imagen2.png https://neuroeconomix.com/es/actualizacion-del-plan-de-beneficios-en-salud-pbs-vigencia-2023/ 2025-02-07T12:13:08+00:00 https://neuroeconomix.com/es/el-regimen-unico-de-tarifas-una-solucion-o-un-riesgo/ 2025-02-07T12:12:11+00:00 https://neuroeconomix.com/es/cual-alternativa-de-evaluacion-economica-de-tecnologias-en-salud-es-mejor-para-las-enfermedades-huerfanas-costo-efectividad-o-impacto-presupuestal/ 2025-02-07T12:11:25+00:00 https://neuroeconomix.com/es/como-quedaria-el-riesgo-en-salud-de-ser-aprobada-la-reforma/ 2025-02-07T12:10:42+00:00 https://neuroeconomix.com/es/que-es-el-control-de-precios-de-medicamentos/ 2025-02-07T12:09:49+00:00 https://neuroeconomix.com/es/es-viable-financieramente-la-reforma-a-la-salud/ 2025-02-07T12:09:08+00:00 https://neuroeconomix.com/es/aciertos-fallas-y-errores-de-la-actual-reforma-a-la-salud-que-debe-hacerse-y-que-errores-evitar-para-mejorar-el-sistema-de-salud-en-colombia/ 2025-02-07T12:08:19+00:00 https://neuroeconomix.com/es/retos-y-problemas-presentes-en-el-acceso-a-los-productos-biologicos-y-a-los-medicamentos-innovadores-como-abordarlos/ 2025-02-07T12:04:11+00:00 https://neuroeconomix.com/wp-content/uploads/2023/06/Imagen1-1.png https://neuroeconomix.com/wp-content/uploads/2023/06/ProductosBiologicos-img1.png https://neuroeconomix.com/wp-content/uploads/2023/06/ProductosBiologicos-img2.png https://neuroeconomix.com/es/los-principales-aspectos-laborales-de-la-reforma-a-la-salud/ 2025-02-07T12:02:57+00:00 https://neuroeconomix.com/es/experiencia-colombiana-y-espanola-en-el-control-de-precios-de-medicamentos/ 2025-02-07T12:02:15+00:00 https://neuroeconomix.com/es/que-sigue-para-la-reforma-a-la-salud/ 2025-02-07T11:52:11+00:00 https://neuroeconomix.com/es/evaluacion-de-tecnologias-sanitarias-para-la-terapia-genica-y-celular-todo-lo-que-debe-saber/ 2025-02-07T11:51:29+00:00 https://neuroeconomix.com/wp-content/uploads/2023/08/img1.png https://neuroeconomix.com/wp-content/uploads/2023/08/img2.png https://neuroeconomix.com/es/se-puede-reformar-el-sistema-de-salud-por-la-via-financiera/ 2025-02-07T11:50:45+00:00 https://neuroeconomix.com/es/financiamiento-de-terapias-celulares-y-geneticas-desafios-y-perspectivas/ 2025-02-07T11:50:05+00:00 https://neuroeconomix.com/wp-content/uploads/2023/08/image.png https://neuroeconomix.com/es/los-tipos-de-empresas-de-las-eps/ 2025-02-07T11:44:50+00:00 https://neuroeconomix.com/es/aspectos-clave-sobre-el-proceso-mediante-el-que-se-establece-la-categoria-de-valor-terapeutico-y-los-dialogos-tempranos/ 2025-02-07T11:42:06+00:00 https://neuroeconomix.com/wp-content/uploads/2023/11/img1-blog-valor-terapeutico.png https://neuroeconomix.com/es/cual-ha-sido-la-experiencia-de-neuroeconomix-con-los-nuevos-lineamientos-del-iets-para-las-evaluaciones-de-tecnologias/ 2025-02-07T11:32:16+00:00 https://neuroeconomix.com/wp-content/uploads/2023/12/2.png https://neuroeconomix.com/wp-content/uploads/2023/12/1.png https://neuroeconomix.com/wp-content/uploads/2023/12/4.png https://neuroeconomix.com/wp-content/uploads/2023/12/3.png https://neuroeconomix.com/es/top-de-los-mas-leidos-de-2023-del-blog-de-neuroeconomix/ 2025-02-07T11:31:59+00:00 https://neuroeconomix.com/es/actualizacion-del-pbs-en-colombia-para-el-2024-resolucion-2366-de-2023-que-cambio/ 2025-02-07T11:27:15+00:00 https://neuroeconomix.com/es/estaban-quebrados-los-hospitales-publicos/ 2025-02-07T11:26:35+00:00 https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img1.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img2.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img3.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img4.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img5.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img6.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img7.png https://neuroeconomix.com/wp-content/uploads/2024/02/BlogFrancisco1_img8.png https://neuroeconomix.com/es/contexto-para-la-inversion-en-el-sector-farmaceutico-en-colombia/ 2025-02-07T11:25:54+00:00 https://neuroeconomix.com/wp-content/uploads/2024/03/SectorFarmaceutico-img1.png https://neuroeconomix.com/wp-content/uploads/2024/03/SectorFarmaceutico-img2.png https://neuroeconomix.com/wp-content/uploads/2024/03/SectorFarmaceutico-img3.png https://neuroeconomix.com/es/el-sistema-de-salud-y-el-modelo-de-atencion-en-salud/ 2025-02-07T11:25:04+00:00 https://neuroeconomix.com/es/abordando-la-equidad-en-la-evaluacion-de-intervenciones-en-salud-mas-alla-del-analisis-de-costo-efectividad/ 2025-02-07T11:24:22+00:00 https://neuroeconomix.com/es/el-giro-directo/ 2025-02-07T11:23:38+00:00 https://neuroeconomix.com/es/los-nuevos-horizontes-de-la-politica-farmaceutica-en-colombia-analisis-de-la-circular-018-de-2024/ 2025-02-07T11:22:57+00:00 https://neuroeconomix.com/wp-content/uploads/2024/05/img1.png https://neuroeconomix.com/wp-content/uploads/2024/05/img2.png https://neuroeconomix.com/wp-content/uploads/2024/05/img3.png https://neuroeconomix.com/wp-content/uploads/2024/05/img4.png https://neuroeconomix.com/es/los-procesos-de-insolvencia-en-el-sector-salud/ 2025-02-07T09:28:00+00:00 https://neuroeconomix.com/es/cambios-en-el-acceso-al-mercado-y-la-regulacion-de-precios-de-medicamentos-en-colombia/ 2025-02-07T09:27:16+00:00 https://neuroeconomix.com/es/el-modelo-de-atencion-en-salud-del-magisterio/ 2025-02-07T09:26:23+00:00 https://neuroeconomix.com/es/el-uso-de-la-inteligencia-artificial-en-el-sector-farmaceutico-areas-de-accion-y-limitaciones/ 2025-02-07T09:25:39+00:00 https://neuroeconomix.com/wp-content/uploads/2024/07/img1_blog-IA.png https://neuroeconomix.com/es/las-empresas-de-salud-entre-las-1000-del-pais/ 2025-02-07T09:24:50+00:00 https://neuroeconomix.com/wp-content/uploads/2024/07/img1-blog1000empresas.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/img2-blog1000empresas.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/img3-blog1000empresas.jpg https://neuroeconomix.com/es/el-sector-farmaceutico-y-la-seguridad-de-los-medicamentos-en-la-era-digital/ 2025-02-07T09:24:07+00:00 https://neuroeconomix.com/es/comparando-el-valor-de-la-unidad-de-pago-por-capitacion-upc/ 2025-02-07T09:23:07+00:00 https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC1-1.png https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC2.png https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC3.png https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC4.png https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC5.png https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC6-1.png https://neuroeconomix.com/wp-content/uploads/2024/08/imgblogUPC7.png https://neuroeconomix.com/es/aprobacion-rapida-de-medicamentos-y-dispositivos-medicos-un-proceso-con-enfoque-global/ 2025-02-07T09:22:17+00:00 https://neuroeconomix.com/es/que-sigue-para-la-reforma-a-la-salud-2/ 2025-02-07T09:21:32+00:00 https://neuroeconomix.com/es/la-evaluacion-clinica-conjunta-en-la-union-europea-un-nuevo-enfoque-en-la-evaluacion-de-tecnologias-sanitarias/ 2025-02-07T09:20:05+00:00 https://neuroeconomix.com/wp-content/uploads/2024/09/img-Eval-Clinica-conjunta2.jpg https://neuroeconomix.com/es/el-funcionamiento-del-sistema-de-salud-de-ser-aprobada-la-reforma/ 2025-02-07T09:19:00+00:00 https://neuroeconomix.com/es/nuevas-tendencias-en-los-sistemas-de-salud-y-su-impacto-en-el-sector-farmaceutico/ 2025-02-07T09:14:39+00:00 https://neuroeconomix.com/es/entendiendo-las-categorias-de-valor-terapeutico-en-colombia-articulo-72-precio-basado-en-valor-y-dialogos-tempranos-con-el-iets/ 2025-02-07T09:08:01+00:00 https://neuroeconomix.com/es/lo-mas-destacado-del-blog-de-neuroeconomix-en-2024-nuestros-articulos-mas-leidos/ 2025-02-07T09:06:44+00:00 https://neuroeconomix.com/es/como-seran-los-dialogos-tempranos-en-colombia/ 2025-02-06T16:37:40+00:00 https://neuroeconomix.com/wp-content/uploads/2025/01/dialogos-jul23_.png https://neuroeconomix.com/es/como-solicitarle-al-iets-revision-y-concepto-de-una-evaluacion-de-tecnologia-sanitaria/ 2025-02-06T16:20:40+00:00 https://neuroeconomix.com/wp-content/uploads/2023/08/evaluaciontec-agos23_img.png https://neuroeconomix.com/es/metodologia-para-la-fijacion-del-precio-de-losmedicamentos-nuevos-circular-016-de-2023/ 2025-02-06T16:15:21+00:00 https://neuroeconomix.com/wp-content/uploads/2023/09/metodologia-sept23-scaled.webp https://neuroeconomix.com/wp-content/uploads/2023/09/fijaciondeprecios_2.webp https://neuroeconomix.com/es/marcos-de-evaluacion-de-tecnologias-digitales-en-salud-que-criterios-valoran/ 2025-02-06T16:07:56+00:00 https://neuroeconomix.com/wp-content/uploads/2023/10/marcos-oct23.png https://neuroeconomix.com/wp-content/uploads/2023/10/marcos-oct23-2.png https://neuroeconomix.com/wp-content/uploads/2023/10/marcos-oct23-1.png https://neuroeconomix.com/es/aplicativos-moviles-en-salud-desarrollados-por-el-ministerio-de-salud-y-proteccion-social-de-colombia/ 2025-02-06T15:49:57+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/aplicativos-oct23_opt-scaled.webp https://neuroeconomix.com/es/historia-clinica-electronica-lineamientos-tecnicos-para-su-interoperabilidad/ 2025-02-06T15:43:20+00:00 https://neuroeconomix.com/wp-content/uploads/2023/11/historia-nov23_1_02.png https://neuroeconomix.com/wp-content/uploads/2023/11/historia-nov23_1_03.png https://neuroeconomix.com/wp-content/uploads/2023/11/historia-nov23_2_04.png https://neuroeconomix.com/es/escaneo-de-horizonte-sabe-que-es-y-como-puede-participar-en-este-proceso/ 2025-02-06T15:32:41+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/1.png https://neuroeconomix.com/wp-content/uploads/2024/02/2.png https://neuroeconomix.com/wp-content/uploads/2024/02/3.png https://neuroeconomix.com/wp-content/uploads/2024/02/4.png https://neuroeconomix.com/wp-content/uploads/2024/02/5.png https://neuroeconomix.com/wp-content/uploads/2024/02/6.png https://neuroeconomix.com/wp-content/uploads/2024/02/7.png https://neuroeconomix.com/wp-content/uploads/2024/02/8.png https://neuroeconomix.com/es/plan-nacional-de-gestion-para-las-enfermedades-huerfanas-raras-en-colombia-conoce-cuales-son-sus-metas-y-acciones/ 2025-02-06T15:27:27+00:00 https://neuroeconomix.com/wp-content/uploads/2024/03/9.png https://neuroeconomix.com/wp-content/uploads/2024/03/10.png https://neuroeconomix.com/wp-content/uploads/2024/03/11.png https://neuroeconomix.com/wp-content/uploads/2024/03/12.png https://neuroeconomix.com/wp-content/uploads/2024/03/13.png https://neuroeconomix.com/wp-content/uploads/2024/03/14.png https://neuroeconomix.com/wp-content/uploads/2024/03/15.png https://neuroeconomix.com/wp-content/uploads/2024/03/16.png https://neuroeconomix.com/wp-content/uploads/2024/03/17.png https://neuroeconomix.com/wp-content/uploads/2024/03/18.png https://neuroeconomix.com/wp-content/uploads/2024/03/19.png https://neuroeconomix.com/es/retiro-de-eps-del-sistema-de-salud-colombiano-sabe-cuales-son-las-opciones-de-salida/ 2025-02-06T15:06:00+00:00 https://neuroeconomix.com/wp-content/uploads/2024/04/20.jpg https://neuroeconomix.com/wp-content/uploads/2024/04/21.jpg https://neuroeconomix.com/wp-content/uploads/2024/04/22.jpg https://neuroeconomix.com/wp-content/uploads/2024/04/23.jpg https://neuroeconomix.com/wp-content/uploads/2024/04/24.jpg https://neuroeconomix.com/wp-content/uploads/2024/04/25.jpg https://neuroeconomix.com/es/rias-mias-pais-y-maite-sabe-que-son-y-cuales-son-sus-diferencias/ 2025-02-06T14:32:07+00:00 https://neuroeconomix.com/wp-content/uploads/2024/05/26.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/27.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/28.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/29.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/30.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/31.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/32.jpg https://neuroeconomix.com/wp-content/uploads/2024/05/33.jpg https://neuroeconomix.com/es/evaluaciones-economicas-que-tipos-existen-y-cuales-son-sus-diferencias/ 2025-02-06T14:27:24+00:00 https://neuroeconomix.com/wp-content/uploads/2024/06/34.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/35.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/36.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/37.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/38.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/39.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/40.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/41.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/42.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/43.jpg https://neuroeconomix.com/wp-content/uploads/2024/06/44.jpg https://neuroeconomix.com/es/inteligencia-artificial-y-aprendizaje-automatico-ai-ml-en-el-area-de-la-salud-cuales-son-sus-usos-y-desafios/ 2025-02-06T14:20:27+00:00 https://neuroeconomix.com/wp-content/uploads/2024/07/45.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/46.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/47.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/48.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/49.jpg https://neuroeconomix.com/wp-content/uploads/2024/07/50.jpg https://neuroeconomix.com/es/inteligencia-artificial-y-aprendizaje-automatico-ai-ml-en-el-area-de-la-salud-como-es-su-proceso-regulatorio/ 2025-02-06T14:14:15+00:00 https://neuroeconomix.com/wp-content/uploads/2025/02/51.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/52.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/53.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/54.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/55.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/56.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/57.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/58.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/59.jpg https://neuroeconomix.com/wp-content/uploads/2025/02/60.jpg https://neuroeconomix.com/es/certeza-de-la-evidencia-cientifica-y-la-fuerza-de-las-recomendaciones-en-salud-son-lo-mismo/ 2025-02-06T14:09:34+00:00 https://neuroeconomix.com/wp-content/uploads/2024/08/61.jpg https://neuroeconomix.com/wp-content/uploads/2024/08/62.jpg https://neuroeconomix.com/wp-content/uploads/2024/08/63.jpg https://neuroeconomix.com/wp-content/uploads/2024/08/64.jpg https://neuroeconomix.com/wp-content/uploads/2024/08/65.jpg https://neuroeconomix.com/wp-content/uploads/2024/08/66.jpg https://neuroeconomix.com/wp-content/uploads/2024/08/67.jpg